The enteral feeding formulas market is segmented based on product, stage, application, end user, and region. Based on products, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the enteral feeding formulas market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the enteral feeding formulas market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.
In 2015, the standard formulas segment accounted for the largest share of the enteral feeding formulas market. This segment is also expected to be the fastest-growing segment in this market during the forecast period of 2015 to 2020. Growth in this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.
The enteral feeding formulas market in the Asia-Pacific region is expected to offer significant growth opportunities for market players during the forecast period. Growth in this regional segment is majorly attributed to the presence of a large patient pool for chronic diseases and disorders, growing incidences of preterm births, increasing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in emerging APAC countries.
The prominent players in the enteral feeding formulas market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) among others.
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: